Losartan, as an angiotensin II Type 1 receptor antagonist, can reduce the apoptosis of spinal cord neurons caused by diabetes through the activation of the nuclear factor erythroid 2-related factor 2/heme oxygenase 1 system (Nrf2/HO-1) [57]. Here, NFE2L2 is linked to diabetes mellitus.